In addition, studies have reported that nuclear pore density increases in senescent cells [20], and nucleoporins such as TPR accumulate after treatment of HDAC inhibitors in the nucleus of cancer cells [22], resulting in the secretion of SASP. The gene discussed is TPR; the disease is cancer.